A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Apr 2024
Historique:
received: 26 03 2024
revised: 23 04 2024
accepted: 24 04 2024
medline: 11 5 2024
pubmed: 11 5 2024
entrez: 11 5 2024
Statut: epublish

Résumé

L-asparaginase is an essential drug used to treat acute lymphoid leukemia (ALL), a cancer of high prevalence in children. Several adverse reactions associated with L-asparaginase have been observed, mainly caused by immunogenicity and allergenicity. Some strategies have been adopted, such as searching for new microorganisms that produce the enzyme and applying protein engineering. Therefore, this work aimed to elucidate the molecular structure and predict the immunogenic profile of L-asparaginase from

Identifiants

pubmed: 38732010
pii: ijms25094788
doi: 10.3390/ijms25094788
pii:
doi:

Substances chimiques

Asparaginase EC 3.5.1.1
Fungal Proteins 0
Epitopes, B-Lymphocyte 0
Epitopes, T-Lymphocyte 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foundation for Research Support of the Federal District
ID : 0193.001797/2017
Organisme : Fundação de Amparo à Pesquisa do Estado de São Paulo
ID : 193.0000919-2020/07
Organisme : Coordenação de Aperfeicoamento de Pessoal de Nível Superior
ID : 001

Auteurs

Kellen Cruvinel Rodrigues Andrade (KCR)

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Mauricio Homem-de-Mello (M)

inSiliTox, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Julia Almeida Motta (JA)

inSiliTox, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Marina Guimarães Borges (MG)

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Joel Antônio Cordeiro de Abreu (JAC)

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Paula Monteiro de Souza (PM)

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Adalberto Pessoa (A)

Department of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-000, Brazil.

Georgios J Pappas (GJ)

Department Cell Biology, Institute Biological Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Pérola de Oliveira Magalhães (P)

Laboratory of Natural Products, Department of Pharmacy, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH